Biotech

All Articles

Navigator rears $100M to establish brand new autoimmune pipeline

.Navigator Medicines has actually equipped itself with $100 million in set A funds as the young biot...

Duality seeks money for ADC tests as IPO wave infects Asia

.China's Duplicity Biotherapeutics has actually filed (PDF) documents for a Hong Kong IPO, seeking a...

YolTech markets China legal rights to genetics modifying treatment for $29M

.4 months after Mandarin genetics editing and enhancing company YolTech Therapeutics took its choles...

Addex sell climbs after Indivior offers up to $300M for compound

.Indivior is getting a little particle allosteric modulator made to deal with compound usage disorde...

Molecular Partners adjusts AML test over 'suboptimal visibility'

.Molecular Partners has identified "suboptimal exposure" to its own tetra-specific T-cell engager as...

Despite blended market, an equity capital resurgence can be being available in Europe: PitchBook

.While the biotech expenditure performance in Europe has actually slowed quite observing a COVID-19 ...

8 months after a $213M fundraise, genetics editor Tome produces reduces

.After bring up $213 thousand in 2023-- among the year's most extensive private biotech rounds-- Tom...

BioMarin builds director team along with biotech veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Biopharma Q2 VC attacked highest level given that '22, while M&ampA slowed

.Financial backing financing right into biopharma cheered $9.2 billion throughout 215 sell the 2nd f...

Bicara, Zenas seek IPOs to drive late-phase resources towards market

.Bicara Rehabs and Zenas Biopharma have given new catalyst to the IPO market along with filings that...